Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 22, 2018
Pharmacy Choice - Pharmaceutical News - Cerus Announces the Fourth Biologics License Application (BLA) Approval for a U.S. Blood Center Customer - September 22, 2018

Pharmacy News Article

 3/13/18 - Cerus Announces the Fourth Biologics License Application (BLA) Approval for a U.S. Blood Center Customer

CONCORD, Calif.(BUSINESS WIRE) Cerus Corporation (NASDAQ: CERS) announced today that The Community Blood Center (CBC) of Appleton, Wisconsin received approval by the U.S. Food and Drug Administration (FDA) on their Biologics License Application (BLA) requesting allowance of interstate distribution of platelets that have been pathogen-reduced with the INTERCEPT Blood System.

CBC Appleton's BLA approval is another important step in our mission to make INTERCEPT the standard of care for transfused blood components, said William Obi Greenman, Cerus president and chief executive officer. With the BLA approval, CBC can now ship INTERCEPT-treated platelets across state lines thereby increasing patient access to safe and effective blood products.

CBC is the fourth blood center to receive BLA approval. Six additional blood centers are awaiting BLA approvals.

Our BLA approval will enable us to supply INTERCEPT-treated platelets for patient care within Wisconsin and throughout the United States, commented John Hagins, CBC's president and chief executive officer. Through increased availability of pathogen reduced products, we can help our hospitals protect patients from transfusion-transmitted infections, including from bacteria and newly emerging pathogens.

The Biologics License Application is a common procedure for blood centers to request permission from FDA to introduce a biologic product into interstate commerce (21 CFR 601.2). Until a blood center obtains a BLA, they are restricted to distributing INTERCEPT-treated products to hospitals within the state in which they are produced. While some blood centers may distribute primarily in-state, many U.S. blood centers have extensive interstate distribution.

ABOUT THE COMMUNITY BLOOD CENTER

Community Blood Center provides 100% of the blood given to patients at 17 Wisconsin and Michigan hospitals. CBC operates neighborhood-donor centers in Appleton, Oshkosh, Little Chute, and Woodruff. Last year, volunteer donors gave more than 50,000 blood donations with CBC. Since 1955, CBC has worked with blood donors to provide a steady, reliable blood supply for hospitals. Today, the blood center remains a nonprofit, independent organization committed to serving hospital patients. See www.communityblood.org for more information.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as chikungunya, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT Red Blood Cell system is in clinical development. See http://www.cerus.com for information about Cerus.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Cerus Corporation

Tim Lee, 925-288-6137

Investor Relations Director

Source: Cerus Corporation



Copyright Business Wire 2018

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 24: Alternatives and Complements to Prescription Pain Management
Sep 25: The New Hypertension Guidelines: What are They Telling Us?
Sep 26: Geriatric Grab-Bag: Erectile Dysfunction, Testosterone Deficiency, and Benign Prostatic Hypertrophy
Sep 27: Shingles Immunization: What’s New?
Sep 30: Sports Nutrition in a Pharmacy Practice
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415